Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.11 is 72% above its 5-year average of -3.93, near the high end of its 5-year range (-9.32–-1.11).
30.41% above its 12-month average of -1.59.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.40.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 19 comparable quarters.
EARNINGS PER SHARE (EPS)
-1.11
EARNINGS PER SHARE (EPS) AVG TTM
-1.59
EARNINGS PER SHARE (EPS) AVG 3Y
-2.87
EARNINGS PER SHARE (EPS) AVG 5Y
-3.93
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+30.41%
CURRENT VS 3Y AVG
+61.37%
CURRENT VS 5Y AVG
+71.79%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Alpha Cognition Inc
Market Cap
$142.11M
Earnings Per Share (EPS)
-1.11
TTM Avg
-1.59
3Y Avg
-2.87
5Y Avg
-3.93
Market Cap
$142.49M
Earnings Per Share (EPS)
2.68
TTM Avg
-1.38
3Y Avg
-6.44
5Y Avg
-7.90
Market Cap
$134.74M
Earnings Per Share (EPS)
-0.18
TTM Avg
-0.17
3Y Avg
-0.17
5Y Avg
-0.09
Market Cap
$149.51M
Earnings Per Share (EPS)
-0.34
TTM Avg
-0.70
3Y Avg
-0.76
5Y Avg
-0.63
Market Cap
$152.16M
Earnings Per Share (EPS)
-0.26
TTM Avg
-0.32
3Y Avg
-0.33
5Y Avg
-0.37
Market Cap
$152.45M
Earnings Per Share (EPS)
-0.26
TTM Avg
-0.53
3Y Avg
-0.57
5Y Avg
-0.55
Market Cap
$153.84M
Earnings Per Share (EPS)
-1.64
TTM Avg
-1.85
3Y Avg
-1.46
5Y Avg
-1.46
Market Cap
$129.14M
Earnings Per Share (EPS)
-0.35
TTM Avg
-0.25
3Y Avg
-0.32
5Y Avg
-0.38
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alpha Cognition Inc (ACOG) | $142.11M | -1.11 | -1.59 | -2.87 | -3.93 |
| Fortress Biotech, Inc. (FBIOP)vs › | $142.49M | 2.68 | -1.38 | -6.44 | -7.90 |
| Freenome, Inc. (FRNM)vs › | $137.29M | N/A | N/A | N/A | N/A |
| AirSculpt Technologies, Inc. (AIRS)vs › | $134.74M | -0.18 | -0.17 | -0.17 | -0.09 |
| Codexis, Inc. (CDXS)vs › | $149.51M | -0.34 | -0.70 | -0.76 | -0.63 |
| Cardiol Therapeutics Inc. (CRDL)vs › | $152.16M | -0.26 | -0.32 | -0.33 | -0.37 |
| Anavex Life Sciences Corp. (AVXL)vs › | $152.45M | -0.26 | -0.53 | -0.57 | -0.55 |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $153.84M | -1.64 | -1.85 | -1.46 | -1.46 |
| Entera Bio Ltd. (ENTX)vs › | $129.14M | -0.35 | -0.25 | -0.32 | -0.38 |
| Cibus, Inc. (CBUS)vs › | $128.24M | -1.65 | -6.80 | -14.48 | -27.17 |
Trailing EPS (TTM)
$-1.11
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -1.17 |
| 2024-12-31 | -2.02 |
| 2023-12-31 | -3.84 |
| 2022-12-31 | -4.46 |
| 2021-12-31 | -9.32 |
| 2020-12-31 | -2.79 |
| 2019-07-31 | -2.73 |
| 2018-07-31 | -0.70 |
